Intelligent Bio Solutions expects 16% year over year growth in fourth quarter revenue

2 days ago 1

Intelligent Bio Solutions (NASDAQ:INBS) announced on Thursday preliminary, unaudited revenue results and key operational highlights for the fiscal fourth quarter and full-year ended June 30, 2025.
The company expects to report fiscal fourth quarter 2025 revenue increases of approximately 16% sequentially and year-over-year, reflecting continued demand for its higher-margin cartridge sales and steady account growth.
Preliminary results indicate sequential revenue growth over both the fiscal third and second quarters.
Intelligent Bio Solutions (NASDAQ:INBS) shares were up 1.28% in premarket trading.